A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)

Abroad (travel likely)RecruitingPHASE2

Conditions

Multiple Sclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • TG Therapeutics Investigational Trial Site, Bihać, Bosnia and Herzegovina

  • TG Therapeutics Investigational Trial Site, Sarajevo, Bosnia and Herzegovina

  • TG Therapeutics Investigational Trial Site, Tuzla, Bosnia and Herzegovina

  • TG Therapeutics Investigational Trial Site, Zenica, Bosnia and Herzegovina

  • TG Therapeutics Investigational Trial Site, Tbilisi, Georgia

  • TG Therapeutics Investigational Trial Site, Tbilisi, Georgia

  • TG Therapeutics Investigational Trial Site, Tbilisi, Georgia

  • TG Therapeutics Investigational Trial Site, Tbilisi, Georgia

  • TG Therapeutics Investigational Trial Site, Shtip, North Macedonia

  • TG Therapeutics Investigational Trial Site, Skopje, North Macedonia

  • TG Therapeutics Investigational Trial Site, Bydgoszcz, Poland

  • TG Therapeutics Investigational Trial Site, Katowice, Poland

  • TG Therapeutics Investigational Trial Site, Katowice, Poland

  • TG Therapeutics Investigational Trial Site, Kielce, Poland

  • TG Therapeutics Investigational Trial Site, Lodz, Poland

  • TG Therapeutics Investigational Trial Site, Poznan, Poland

  • TG Therapeutics Investigational Trial Site, Warsaw, Poland

  • TG Therapeutics Investigational Trial Site, Belgrade, Serbia

  • TG Therapeutics Investigational Trial Site, Kragujevac, Serbia

  • TG Therapeutics Investigational Trial Site, Chernihiv, Ukraine

  • TG Therapeutics Investigational Trial Site, Chernihiv, Ukraine

  • TG Therapeutics Investigational Trial Site, Ivano-Frankivsk, Ukraine

  • TG Therapeutics Investigational Trial Site, Ivano-Frankivsk, Ukraine

  • TG Therapeutics Investigational Trial Site, Ivano-Frankivsk, Ukraine

  • TG Therapeutics Investigational Trial Site, Kyiv, Ukraine

  • TG Therapeutics Investigational Trial Site, Kyiv, Ukraine

  • TG Therapeutics Investigational Trial Site, Kyiv, Ukraine

  • TG Therapeutics Investigational Trial Site, Kyiv, Ukraine

  • TG Therapeutics Investigational Trial Site, Kyiv, Ukraine

  • TG Therapeutics Investigational Trial Site, Kyiv, Ukraine

  • TG Therapeutics Investigational Trial Site, Lviv, Ukraine

  • TG Therapeutics Investigational Trial Site, Lviv, Ukraine

  • TG Therapeutics Investigational Trial Site, Odesa, Ukraine

  • TG Therapeutics Investigational Trial Site, Poltava, Ukraine

  • TG Therapeutics Investigational Trial Site, Tbilisi, Ukraine

  • TG Therapeutics Investigational Trial Site, Ternopil, Ukraine

  • TG Therapeutics Investigational Trial Site, Uzhhorod, Ukraine

  • TG Therapeutics Investigational Trial Site, Vinnytsia, Ukraine

  • TG Therapeutics Investigational Trial Site, Vinnytsia, Ukraine